Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment

Corticosteroids (CS) are standard therapy for the treatment of Duchenne's muscular dystrophy (DMD). Even though they decrease inflammation, they have limited efficacy and are associated with significant side effects. There is therefore the need for new protolerogenic treatments to replace CS. D...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Ouisse, Laure-Hélène, Remy, Séverine, Lafoux, Aude, Larcher, Thibaut, Tesson, Laurent, Chenouard, Vanessa, Guillonneau, Carole, Brusselle, Lucas, Vimond, Nadège, Rouger, Karl, Péréon, Yann, Chenouard, Alexis, Gras-Le Guen, Christèle, Braudeau, Cécile, Josien, Régis, Huchet, Corinne, Anegon, Ignacio
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746111/
https://ncbi.nlm.nih.gov/pubmed/31552055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02131
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars